BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32490903)

  • 1. PANCREATIC STEATOSIS: A NEW DIAGNOSIS AND THERAPEUTIC CHALLENGE IN GASTROENTEROLOGY.
    Paul J; Shihaz AVH
    Arq Gastroenterol; 2020; 57(2):216-220. PubMed ID: 32490903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic steatosis: Is it related to either obesity or diabetes mellitus?
    Pezzilli R; Calculli L
    World J Diabetes; 2014 Aug; 5(4):415-9. PubMed ID: 25126389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enlarged pancreas: not always a cancer.
    Calculli L; Festi D; Pezzilli R
    Hepatobiliary Pancreat Dis Int; 2015 Feb; 14(1):107-8. PubMed ID: 25655299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty pancreas disease: clinical impact.
    Blaho M; Dítě P; Kunovský L; Martínek A
    Vnitr Lek; 2018; 64(10):949-952. PubMed ID: 30590942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Alcoholic Fatty Pancreas Disease (NAFPD): A Silent Spectator or the Fifth Component of Metabolic Syndrome? A Literature Review.
    Romana BS; Chela H; Dailey FE; Nassir F; Tahan V
    Endocr Metab Immune Disord Drug Targets; 2018; 18(6):547-554. PubMed ID: 29595117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the metabolic syndrome: Nonalcoholic fatty pancreas disease.
    Catanzaro R; Cuffari B; Italia A; Marotta F
    World J Gastroenterol; 2016 Sep; 22(34):7660-75. PubMed ID: 27678349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-Alcoholic Fatty Pancreatic Disease: A Review of Literature.
    Tariq H; Nayudu S; Akella S; Glandt M; Chilimuri S
    Gastroenterology Res; 2016 Dec; 9(6):87-91. PubMed ID: 28058076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic Lipomatosis: An Extensive Pictorial Review.
    Coulier B
    J Belg Soc Radiol; 2016 Feb; 100(1):39. PubMed ID: 30151451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between pancreas steatosis and metabolic syndrome: A systematic review and meta-analysis.
    Bi Y; Wang JL; Li ML; Zhou J; Sun XL
    Diabetes Metab Res Rev; 2019 Jul; 35(5):e3142. PubMed ID: 30767421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of lipomatous pseudohypertrophy of the pancreas diagnosed by typical imaging.
    Yasuda M; Niina Y; Uchida M; Fujimori N; Nakamura T; Oono T; Igarashi H; Ishigami K; Yasukouchi Y; Nakamura K; Ito T; Takayanagi R
    JOP; 2010 Jul; 11(4):385-8. PubMed ID: 20601816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic Fatty Pancreas Disease.
    Shah N; Rocha JP; Bhutiani N; Endashaw O
    Nutr Clin Pract; 2019 Oct; 34 Suppl 1():S49-S56. PubMed ID: 31535735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic Fatty Pancreas Disease: Clinical Consequences.
    Dite P; Blaho M; Bojkova M; Jabandziev P; Kunovsky L
    Dig Dis; 2020; 38(2):143-149. PubMed ID: 31865317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothyroidism and subclinical hypothyroidism are associated with fatty pancreas (Non-Alcoholic Fatty Pancreas Disease).
    Bayyigit A; Gokden Y; Onol S; Ozek FZ; Saglam S; Adas M
    Diabetes Metab Res Rev; 2024 Feb; 40(2):e3720. PubMed ID: 37691570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipid accumulation in the pancreas: clinical significance of NAFPD (non-alcoholic fatty pancreas disease)].
    Jermendy G
    Orv Hetil; 2022 Oct; 163(44):1735-1742. PubMed ID: 36309887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic steatosis and metabolic pancreatic disease: a new entity?
    Caldart F; de Pretis N; Luchini C; Ciccocioppo R; Frulloni L
    Intern Emerg Med; 2023 Nov; 18(8):2199-2208. PubMed ID: 37462859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The correlation between pancreatic steatosis and metabolic syndrome in a Chinese population.
    Zhou J; Li ML; Zhang DD; Lin HY; Dai XH; Sun XL; Li JT; Song LY; Peng H; Wen MM
    Pancreatology; 2016; 16(4):578-83. PubMed ID: 27050733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic and pancreatic fat as imaging biomarkers of metabolic syndrome.
    Ballester-Vallés C; Flores-Méndez J; Delgado-Moraleda J; Ballesteros Martín-Portugués A; Merino-Torres JF; Fornés-Ferrer V; Martí-Bonmatí L
    Radiologia (Engl Ed); 2020; 62(2):122-130. PubMed ID: 31447050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PANCREATODUODENECTOMY DUE TO LIPOMATOUS PSEUDOHYPERTROPHY OF THE PANCREAS.
    Torres OJM; Vasques RR; Barros Júnior CM; Sauaia Filho GA; Mouchrek BDM; Rocha ML; Santos RAP; Falcão MV; Moraes Júnior JMA
    Arq Bras Cir Dig; 2023; 36():e1754. PubMed ID: 37729275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic fatty pancreas disease - practices for clinicians.
    Pinte L; Balaban DV; Băicuş C; Jinga M
    Rom J Intern Med; 2019 Sep; 57(3):209-219. PubMed ID: 30901317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rare case of lipomatous pseudohypertrophy of the pancreas.
    Luu VD; Duc NM; My TT; Viet NK; Bang LV; Thong PM
    Radiol Case Rep; 2021 Jun; 16(6):1363-1367. PubMed ID: 33897930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.